ВестникНОМУС
.
Сборникматериалов
конкурса
литературных
обзоров
-2012
213
16.
Influence of HAART on the clinical course of HIV-1-infected patients with
progressive multifocal leukoencephalopathy: results of an observational multicenter
study [text] / V. Falko [et al.] // J. Acquir Immune. Def. Synd. – 2008. –Vol. 49. –P.
26-31.
17.
Failure of cytarabine in progressivemultifocal leukoencephalopathy associated
with human immunodeficiency virus infection. AIDS Clinical Trials Group 243
Team [text] / C.D. Hall [et al.] // NEJM. –1998. –Vol. 338. –P. 1345-1351.
18.
From the archives of the AFIP central nervous system infections associated
with human immunodeficiencyvirus infection: radiologicpathologic correlation [text]
/ A.B. Smith [et al.] // RadioGraphics. –2008. –Vol. 28. –P. 2033-2058.
19.
First identification and molecular characterization of lymphotropic
polyomavirus in peripheral blood from patients with leukoencephalopathies[text] / S.
Delbue [et al.] // J. ofClinicalMicrob. –2008. –Vol.46, N7. –P. 2461-2462.
20.
Emerging polyomaviruses in the human population [text] / U. Moens [et al.] //
Reviews in Infection. – 2010. -Vol. 1. –P. 59-93.
21.
Human exposure to SV40: review and comment[text] / K. Shah, N. Nathanson
// Am. J. of Epidemiology. – 1976. -Vol.103. –P. 1-12.
22.
KI, WU andMerkel cell polyomaviruses: a new era for human polyomavirus
research [text] / T. Dalianis [et al.] // Seminars in Cancer Biology. – 2009. - Vol. 19.
–P. 270-275.
23.
Merkel cell polyomavirus and two previously unknown polyomaviruses are
chronically shed from human skin [text] / R.M. Schowalter [et al.] // Cell Host and
Microbe. –2010. –Vol.7, N6. –P. 509-515.
24.
New human papovavirus (B.K.) isolated from urine after renal
transplantation[text] / S.D. Gardner [et al.] // The Lancet. – 1971. - Vol.1, N.7712. –
P. 1253-1257.
25.
PML-IRIS in patientswithHIV infection: clinical manifestations and treatment
with steroids [text] /K.Tan // Neurology. – 2009. –Vol. 72. –P. 1458-1464.
26.
Progressive multifocal leukoencephalopathy; a hitherto unrecognized
complication of chronic lymphatic leukemia and Hodgkins disease [text] /
K.E.Astrom, E.L.Mancall, E.P. Richardson // Brain. – 1958. –Vol. 81. –P. 93-111.
27.
Progressive multifocal leukoencephalopathy: a national estimate of frequency
in systemic lupus erythematosus and other rheumatic diseases [text] / E.S.Molloy,
L.H.Calabrese // ArthritisRheum. – 2009. –Vol.60. –P. 3761-3765.
28.
Progressive multifocal leukoencephalopathy after natalizumab therapy for
Crohn’s disease [text] / G.VanAssche [et al.] // NEJM. – 2005. –Vol. 353. – P. 362-
368.
29.
Progressive multi focal leukoencephalopathy in patients on highly active
antiretroviral therapy: survival and risk factors of death[text] / C.Wyen [et al.] // J.
Acquir Immune. Def. Synd. – 2004. –Vol. 37. –P. 1263-1268.
30.
Progressive multifocal leukoencephalopathy in HIV-1 infection [text] /
P.Cinque [et al.] // Lancet Infect. Dis. –2009. –Vol. 9. –P. 625-636.
